Imprint

ABX-CRO
advanced pharmaceutical services
Forschungsgesellschaft mbH

 

Blasewitzer Strasse 78-80
D-01307 Dresden · Germany
Telephone: +49  . 351 . 21444-0
Telefax: +49 . 351 . 21444 -15

Dr. Andreas Kluge
General Manager
e-mail: moc.o1569125194rc-xb1569125194a@ofn1569125194i1569125194

Amtsgericht Dresden HRB21253
USt-ID DE 813 528 365

CONTACT

For any queries regarding licensing and pricing please contact the sales representative in your area. Further training and support is provided by ABX-CRO.

Sales Europe

Dr. Joachim Bender
QDOSE® EU Representative

moc.o1569125194rc-xb1569125194a@eso1569125194dq1569125194
Phone +49 (0) 351 21444-211

Support & Development

ABX-CRO advanced pharmaceutical
services Forschungsgesellschaft

Blasewitzer Straße 78-80
01307 Dresden, Germany

Phone +49 (0) 351 21444-212
Telefax +49 (0) 351 214 44-15

moc.o1569125194rc-xb1569125194a@eso1569125194dq1569125194
www.abx-cro.com

Sales US

Joseph Saldarini
QDOSE® US Representative

moc.o1569125194rc-xb1569125194a@ini1569125194radla1569125194s1569125194
Phone +1 336 2556120

ABX-CRO’s quality management is certified according to ISO 9001:2015 as well as ISO 13485:2016.
QDOSE® conforms to the European Medical Device Directive 93/42/EEC and is CE marked as
Medical Product (Class IIa) for clinical use inside the European Union.
Outside the EU, QDOSE® can be used for research purposes only.